You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company was able to ramp up recruitment for its pivotal ECLIPSE trial after hurdles caused a falloff during the earlier months of the COVID-19 pandemic.
The assay provides comprehensive genomic information to oncologists from a blood draw, using targeted next-generation sequencing of circulating cell-free DNA.
The sequencing firm said infectious disease research, diagnostics, screening, and surveillance could all increase demand for its NGS products.
Researchers used the system to precisely deplete mRNA transcripts in zebrafish embryos and showed that it can also be used in medaka, killifish, and mouse.
News items for the week of August 3, 2020.
The report also identified opportunities to improve adoption through dissemination of evidence supporting the clinical and economic utilization of testing.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.